S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Cumberland PharmaceuticalsAridis PharmaceuticalsInflarxAlpine Immune SciencesEntasis Therapeutics
SymbolNASDAQ:CPIXNASDAQ:ARDSNASDAQ:IFRXNASDAQ:ALPNNASDAQ:ETTX
Price Information
Current Price$5.43$6.02$2.33$2.55$5.80
52 Week RangeN/ABuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationN/ABuyHoldBuyBuy
Consensus Price TargetN/A$21.75$17.43$13.00$18.60
% Upside from Price TargetN/A261.30% upside648.01% upside409.80% upside220.69% upside
Trade Information
Market Cap$83.61 million$50.89 million$61.53 million$51.81 million$75.69 million
Beta0.16-0.8-1.511.85N/A
Average Volume19,9858,544766,29314,00613,247
Sales & Book Value
Annual Revenue$40.74 million$2.76 millionN/A$700,000.00$5 million
Price / Sales2.0519.43N/A67.6515.24
Cashflow$0.07 per shareN/AN/AN/AN/A
Price / Cash76.64N/AN/AN/AN/A
Book Value$3.58 per share$3.25 per share$7.64 per share$3.22 per share$6.33 per share
Price / Book1.521.85N/A0.790.92
Profitability
Net Income$-6,960,000.00$-22,100,000.00$-35,210,000.00$-36,490,000.00$-32,950,000.00
EPS($0.12)($7.01)($1.40)($2.63)($12.31)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio12.93N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-9.87%-660.52%N/AN/AN/A
Return on Equity (ROE)5.04%-130.22%-28.37%-94.28%N/A
Return on Assets (ROA)2.65%-103.95%-26.69%-74.07%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.37%N/AN/A0.27%0.03%
Current Ratio2.33%2.66%10.67%4.56%9.11%
Quick Ratio1.85%2.67%10.67%4.56%9.11%
Ownership Information
Institutional Ownership Percentage31.03%0.53%17.06%46.91%64.99%
Insider Ownership Percentage39.38%23.04%N/A75.10%23.10%
Miscellaneous
Employees80233648N/A
Shares Outstanding15.37 million8.91 million25.96 million18.57 million13.14 million
Next Earnings Date11/12/2019 (Estimated)11/12/2019 (Estimated)11/20/2019 (Estimated)11/14/2019 (Estimated)11/13/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
 Cumberland PharmaceuticalsAridis PharmaceuticalsInflarxAlpine Immune SciencesEntasis Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel